EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

CLINICAL COMPARATIVE STUDY FOR THE EFFECT OF ANTIHYPERTENSIVE DRUGS ON SERUM OXIDANT-ANTIOXIDANTS STATUS

Ruaa. K. Abbas, Prof. Dr. Raid M. H. Al-Salih* and Assist Prof. Dr. Sajid. H. Guzar

ABSTRACT

The aim of this study was to investigate the effect of antihypertensive drugs on serum oxidant-antioxidants status. Using the lipid peroxidation marker, malondialdehyde (MDA) and preventative antioxidants ceruloplasmin (Cp) and albumin (Alb), in serum of patients with hypertension. Blood samples were obtained from (160) patients treated with different antihypertensive drugs, as well as (40) healthy subjects as a control group. They divided into five groups as the following: control Group:- Included forty healthy subjects aged (40-70 years). ACEIs Group:- Included forty patients with Angiotensin-Converting Enzyme Inhibitors (ACEIs) drugs aged (40-70 years). ARBs Group:- Included forty patients with Angiotensin-II Receptor Blockers (ARBs) drugs aged (40-70 years). β.blockers Group:- Included forty patients with Beta.blockers drugs aged (40-70 years). CCBs Group:- Included forty patients with Calcium Channel Blockers (CCBs) drugs aged (40-70 years). Results: The results show non-significant differences in serum MDA between each of ACEIs and ARBs drugs groups, in comparison with control group (P≤0.05). While a significant increase in the levels of serum MDA can be observed in two patients groups with β.blockers and CCBs drugs in comparison with control group when compared with groups of ACEIs and ARBs drugs. Ceruloplasmin (CP) also shown significant increase in all patient groups in comparison with control group, as well as significant increase in the levels of serum CP can be observed in β.blockers and CCBs drugs groups in comparison with groups of ACEIs and ARBs drugs, While serum albumin (Alb) levels have non significantly (P≤0.05) differences in all patients groups.

Keywords: Hypertension, Antihypertensive drugs, Oxidant-antioxidants Status.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 December 2021 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR: DECEMBER ISSUE PUBLISHED

    DECEMBER Issue has been successfully launched on 1 December 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )